This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Bet on These Top Value ETFs Now
by Sweta Jaiswal, FRM
Several factors are creating a conducive environment for value stocks to outperform their growth counterparts this year.
Here's Why Investors Can Bet on These Value ETFs
by Sweta Jaiswal, FRM
Several factors are creating a conducive environment for value stocks to outperform their growth counterparts this year.
Should SPDR Portfolio S&P 500 Value ETF (SPYV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPYV
6 Keys to a Healthy ETF Portfolio
by Sweta Killa
Similar to the six vital nutrients required for good health, we have highlighted six keys for building a healthy ETF portfolio.
S&P 500 Tops 4,000: Are ETFs Awaiting More Gains?
by Sanghamitra Saha
The S&P 500 topped 4,000-mark lately. Market buzz and industry fundamentals indicate that there is room for more growth.
Don't Let Underperformance in Growth ETFs Fool You
by Sanghamitra Saha
Focus on the technology sector, rising virus cases, talks of a hike in capital gains tax and still-low rates should bring the growth investing back in favor.
Tax Hike Not a Big Concern? Play S&P 500 ETFs
by Sanghamitra Saha
Talks are doing rounds that Centrist Democrats in Congress are apparently opposing Biden's corporate and capital gains tax proposal. We may see a lesser hike in tax rates if at all there is a tax hike in the near term.
Top-Ranked Value ETFs to Add to Your Portfolio
by Sweta Jaiswal, FRM
Accelerated coronavirus vaccine rollout, a fresh round of fiscal stimulus and the economic reopening may lead to faster U.S. economic recovery and present a strong case for outperformance by value ETFs in 2021.
Fed Bumps Up Economic Growth Forecasts: ETFs to Play
by Sanghamitra Saha
As widely expected, the Fed held interest rates steady at a near-zero level in its latest meeting.
4 Sectors & Their ETFs Offering Great Value Now
by Sanghamitra Saha
Wall Street has rallied nicely this year on vaccine and fiscal stimulus optimism. But gains have mainly been supported by value stocks.